Currently, there are 239.82M common shares owned by the public and among those 215.34M shares have been available to trade.
The company’s stock has a 5-day price change of -0.64% and -0.11% over the past three months. GENI shares are trading 8.44% year to date (YTD), with the 12-month market performance up to 69.01% higher. It has a 12-month low price of $5.09 and touched a high of $11.40 over the same period. GENI has an average intraday trading volume of 4.14 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.03%, -6.17%, and 4.90% respectively.
Institutional ownership of Genius Sports Limited (NYSE: GENI) shares accounts for 86.52% of the company’s 239.82M shares outstanding.
It has a market capitalization of $2.39B and a beta (3y monthly) value of 1.87. The earnings-per-share (ttm) stands at -$0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.33% over the week and 1.37% over the month.
Earnings per share for the fiscal year are expected to increase by 103.89%, and 1021.49% over the next financial year.
Looking at the support for the GENI, a number of firms have released research notes about the stock. BTIG Research stated their Buy rating for the stock in a research note on April 22, 2025, with the firm’s price target at $11-$12. Deutsche Bank coverage for the Genius Sports Limited (GENI) stock in a research note released on April 21, 2025 offered a Buy rating with a price target of $12. B. Riley Securities was of a view on March 18, 2025 that the stock is Buy, while Guggenheim gave the stock Buy rating on March 18, 2025, issuing a price target of $12. Citigroup on their part issued Buy rating on June 13, 2024.
